Research analysts at Piper Sandler started coverage on shares of Cara Therapeutics (NASDAQ:TVRD - Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The brokerage set an "overweight" rating and a $78.00 price target on the stock. Piper Sandler's price target suggests a potential upside of 198.85% from the company's previous close.
Several other equities analysts have also commented on TVRD. Oppenheimer started coverage on shares of Cara Therapeutics in a report on Wednesday, May 21st. They issued an "outperform" rating and a $65.00 price objective on the stock. Wall Street Zen upgraded Cara Therapeutics to a "hold" rating in a research note on Saturday, May 24th.
Read Our Latest Stock Analysis on TVRD
Cara Therapeutics Stock Down 0.0%
NASDAQ TVRD traded down $0.01 during trading hours on Thursday, reaching $26.10. The company had a trading volume of 39,665 shares, compared to its average volume of 23,940. Cara Therapeutics has a 1-year low of $8.13 and a 1-year high of $34.31.
About Cara Therapeutics
(
Get Free Report)
Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells.
Featured Stories
Before you consider Cara Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cara Therapeutics wasn't on the list.
While Cara Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
